文献速递青光眼角膜与眼表疾病

波士顿1型人工角膜患者中青光眼手术的作用与时机评估

Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients.
PubMed 文献 · Am J Ophthalmol · 2021-09-17

这项回顾性比较研究纳入2008至2017年植入波士顿1型人工角膜的100眼,分析青光眼手术的作用与时机。原有青光眼者中,人工角膜术后再行青光眼手术的进展率高于术前手术或仅药物治疗;人工角膜术后新发青光眼者药物与手术结局相似。结论推荐原有青光眼者应在人工角膜植入前或同时行青光眼手术。

要点

  • 原有青光眼者人工角膜术后再手术的进展率高于术前手术或药物治疗。
  • 青光眼手术未增加并发症,但药物治疗者维持视力≥20/200的比例更低。
  • 新发青光眼者药物与手术的进展、视力及并发症无显著差异。

核心结论

  • 原有青光眼者应在人工角膜植入前或同时行青光眼手术。
  • 人工角膜眼行青光眼手术未增加并发症。
  • 视力潜力好的人工角膜眼应尽早行青光眼手术以优化控制。

研究设计与样本

  • 回顾性、比较性、非随机临床研究,单中心2008至2017年100眼(100例)植入人工角膜且诊断青光眼。
  • 分为原有青光眼组与人工角膜术后新发青光眼组,再按药物或手术管理划分。
  • 青光眼手术包括青光眼引流装置植入、小梁切除术和睫状体光凝。

主要发现

  • 原有青光眼72眼中27眼(38%)在人工角膜术前手术(18眼GDD),45眼(62%)仅药物治疗。
  • 仅药物治疗者中19眼(42%)人工角膜术后需手术(16眼GDD)。
  • 新发青光眼28眼中12眼(43%)人工角膜术后手术(9眼GDD)。

临床怎么用

  • 原有青光眼患者应考虑在人工角膜植入前或同时行青光眼手术。
  • 人工角膜眼行青光眼手术未增加并发症,原有或新发青光眼均可考虑手术。
  • 视力潜力好的人工角膜眼应尽早行青光眼手术以优化青光眼控制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To determine the role and optimal timing of glaucoma surgery in relation to Boston keratoprosthesis type 1 (KPro) implantation. DESIGN: Retrospective, comparative, nonrandomized clinical study. METHODS: Single-center study of a total of 100 eyes (100 patients) implanted with a KPro between 2008 and 2017, and diagnosed with glaucoma before or after KPro. Patients were separated into 2 groups: those with preexisting glaucoma and those who developed de novo glaucoma after KPro. Groups were then divided based on whether patients were medically or surgically managed. Glaucoma surgery included glaucoma drainage device (GDD) implantation, trabeculectomy, and cyclophotocoagulation (CPC). Primary outcomes included best-corrected visual acuity (BCVA), glaucoma progression, and complications. Differences in outcomes were compared using parametric and nonparametric tests, as well as log-rank test to compare time-to-outcome events. RESULTS: Among 72 eyes with preexisting glaucoma, 27 (38%) had glaucoma surgery before KPro (18 GDD), whereas 45 (62%) were medically managed only. Among the latter, 19 (42%) needed glaucoma surgery post-KPro (16 GDD). Among 28 eyes with de novo glaucoma, 12 (43%) had glaucoma surgery post-KPro (9 GDD). For eyes with preexisting glaucoma, glaucoma progression was greater with glaucoma surgery performed post-KPro (100%) compared with pre-KPro (74%, P = .016) and to medical management (54%, P = .002). No increase in complications were observed with glaucoma surgery compared to medications only (P > .05), whereas fewer eyes maintained a BCVA of 20/200 or better over time with medical management (P = .013). Eyes with de novo glaucoma had similar progression, BCVA, and complications between medical and surgical care (P > .05). CONCLUSIONS: Glaucoma surgery should be performed before or at the same time as KPro implantation in eyes with preexisting glaucoma. Complication rates are not increased when glaucoma surgery is performed in KPro eyes with either preexisting or de novo glaucoma. To ensure optimal glaucoma control, glaucoma surgery should be performed as early as possible in KPro eyes with good visual potential.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Geoffrion D, Hassanaly SI, Marchand M, et al. Assessment of the Role and Timing of Glaucoma Surgery in Boston Keratoprosthesis Type 1 Patients. Am J Ophthalmol. 2021. PMID: 34543660. doi:10.1016/j.ajo.2021.09.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。